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transfer may effectively induce the overexpression of two immunosuppressive cytokines 
simultaneously and generate synergistic immunosuppression in cardiac allograft, and 
promote the cardiac allograft tolerance. 
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409-5 Treatment of Experimental Heart Failure With 
Hepatocyte Growth Factor 
Vasant Javasankar, Timothy J. Pirolli, Lawrence T. Bish, Mark F. Berry, Joseph Woo, Ii 
Lee Sweeney, Timothy J. Gardner, University of Pennsylvania School of Medicine, 
Philadelphia, PA 
Background: Healt failure following myocardial infarction (Ml) is a significant cause of 
morbidity and mortality and remains a difficult therapeutic challenge. Hepatocyte growth 
factor (HGF) is a potent angiogenic and anti-apoptotic protein whose receptor is upregu- 
lated following Ml. This study was designed to investigate the ability of HGF to prevent 
the develooment of heart failure in a rat model of experimental Ml. Methods: Rats under- 
went dired intramyocardial injection with replication-deficient adenovirus encoding HGF 
fn=7) or null virus es control fn=7) three weeks followina lioation of the left anterior _ 1  
descending coronary ariery. Analysis of the following was pedormed three weeks after 
InjectIon: cardiac function by pressure-volume conductance catheter measurements, LV 
wall thickness, angiogenesis by Von Willebrand’s Factor staining, and apoptosis by the 
TUNEL assay. The expression levels of HGF and the anti-apoptotic factor Bcl-2 were 
analyzed by Western blot. Results: Adeno-HGF treated animals demonstrated greater 
preservation of maximum LV pressure (HGF 77+2.9 vs Null 64i4.8 mm Hg, p=.O4), max- 
imum dP/dt (3024+266 vs 1907*360 mmtlgisec, p=.O3), maximum dV/dt (133&O vs 
84~6 plisec, p=.O4), and LV border zone wall thickness (1.98-t.06 vs 1.53k.07 mm. 
p=.OO5). Angiogenesis was enhanced (151210 vs 9Oi5 endothelial cells/hpf. p=.OO3), 
and apoptosis was reduced (3.9eO.3 vs 8.2iO.5%, p=.OO4). Increased expression of 
HGF and Bcl-2 protein was observed in the Adeno-HGF treated group. Conclusions: 
Overexpression of HGF three weeks post-MI results in enhanced angiogenesis. reduced 
apoptosis, greater preservation of ventricular geometry, and preservation of cardiac con- 
tractile function. This technique may be useful to treat or prevent post-infarction heart fail- 
ure. 
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410-2 High-Risk Clinical Features Predict Enhanced Post- 
infarction Myocardial Apoptosis and the Need to 
Achieve Infarct-Related Artery Patency 
Antonio Abbate, Giuseppe G. Biondi-Zoccai, Rossana Bussani. Debora Camilot. 
Alessandro Petrolini, Furio Silvestri, Luigi M. Biasucci, Alfonso Baldi. Catholic University 
of Rome, Rome, Italy 
Background. Infarct-related artery (IRA) patency after AMI is associated with favorable 
LV remodeling and beneficial clinical effects, in particular in patients with high risk fea- 
tures. As it has been reported that IRA patency is associated with reduced post-infarction 
apoptotic rate (AR), aim of our study was to assess whether IRA status had a different 
impact on AR in high- vs low-risk patients. 
Methods Co-localization for TUNEL and caspase-3 was used to calculate the AR at site 
of infarction at time of death in hearts of 30 subjects who died 10 to 62 days after AMI. 
Suitable positive and negative controls were performed. The Norris coronary prognostic 
index (NI) was calculated computing age, presence of pulmonary congestion, heart size 
and history of previous additional AMI. in order to define patients’ individual risk at time of 
hospitalization. According to the NI (4 vs. >7). subjects were divided into low-risk and 
high-risk groups, since a Nl>7 carries an approximate 3-fold higher shop- and long-term 
risk of death after AMI. 
Results. Twenty subjects (67%) had persistent IRA occlusion at time of death and in 
these patients AR was significantly higher than in those with open IRA (PcO.001). How- 
ever the impact of IRA occlusion on AR was significantly different comparing high- vs 
low-risk subjects. In particular, AR was lo-fold higher in high-risk subjects with persistent 
IRA occlusion (26.1%[20.4-26.7%]) vs those with open IRA (2.3%[0.6-3.5%];P=O.O02) 
and non-significantly different in low-risk subjects with vs those without IRA occlusion 
(8.2%[2.5-17.5%] vs 5.4%[1.5-7.9%];P=0.48).Conclusion.s. In high-risk subjects, a sig- 
nificantly higher AR is associated with persistent IRA occlusion late post AMI. The 
diverse impact of IRA occlusion on AR in subjects with different nsk profile may explain 
the greater benefit obtained with coronary reperfusion in high-risk subjects, particularly 
those with LV dysfunction. The overall lower AR in low-risk subjects, however, may be 
correlated with the betler long-term prognosis after AMI in this case, independently from 
the IRA status, suggesting the need to achieve IRA patency mostly in high risk patients. 
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41 o-1 Bone Marrow Derived Cardiomyocytes Are Present in 
Adult Human Heat-l 
Ariun Deb, Shaohua Wang, Kimberly Skelding, David Simper, Noel Caplice, Mayo Clinic, 
Rochester, MN 
Background: Recent studies have identified cardiomyocytes of extracardiac origin in 
human hearts following gender mismatched cardiac transplantation but the exact source 
of these myocyte progenitors is currently unknown. 
Methods: Hearts of female patients (n=4) who had undergone gender mismatched bone 
marrow transplantation (BMT) were recovered at autopsy and analyzed for the presence 
of Y-chromosome positive cardiomyocytes. Four female patients with gender matched 
BMT served as controls. Fluorescence in situ hybridization (FISH) for Y chromosome 
was performed on paraffin embedded sections to identify cells of bone marrow origin with 
concomitant immunofluorescent labeling for a-sarcomeric actin to identify cardiomyo- 
cytes. 
Results: All patients with gender mismatched BMT were aged between 20 and 50 years 
at the time of death. The time duration from BMT to death varied between 5 weeks and 
20 months. With the exception of one patient who had sudden death, all the others died 
from complications of BMT. A total of 16000 cardiomyocyte nuclei were analyzed approx- 
imating 2000 nuclei per patient. The mean percentage of Y chromosome positive cardi- 
omyocytes in patients with sex mismatched BMT was 0.2 * 0.12% with a range of 0.1%. 
0.4%. No evidence of inflammation was found in any of the hearts studied. Not a single Y 
chromosome positive csrdiomyocyte was identified in any of the 8000 cardiomyocyte 
nuclei counted in control patients. lmmunofluorescent co-staining for basement mem- 
brane laminin and chromosomal ploidy analysis with FISH showed no evidence of either 
pseudonuclei or cell fusion in any of the chimeric cardiac myocytes identified. 
Conclusions: These data establish for the first time human bone marrow as a source of 
extra cardrac progenitor cells capable of de nova cardiomyocyte formation. The clinical 
significance of this finding will depend on further studies aimed at elucidating the mecha- 
nisms of mobilization, homing and differentiation of these cells. 
llene Claudius, Yueh-Tze Lsn. Ruey-Kang Chang, Glenn T. Wet&, Juan C. Alejos. 
University of California, Los Angeles, Los Angeles, CA 
Background: We sought to determine if B-type natriuretic peptide (BNP) levels sre pre- 
dictive of rejection or vasculopathy in children following orthotopic heart transplantation 
(OHT). BNP, an endogenous hormone produced in the ventricles, may serve as an alter- 
native to endomyocardial biopsy and angiography for detecting rejection or transplant 
coronary artery disease (TCAD) in a select group of patients. Currently, no studies exist 
evaluating the sensitivity of BNP for identifying graft pathology in children. 
Methods We conducted a retrospective review of pediatric OHT patients who under- 
went catheterization, biopsy, and echocardiogram between January and June of 2002. A 
Mann-Whitney U test was used to compare the BNP levels in patients with evidence of 
pathology and those without. Sensitivity, specificity, and predictive value of BNP to detect 
cardiac pathology were also calculated using standard statistical methods. 
Results A total of 30 patients were studied, 8 patients with evidence of either rejection 
or TCAD, either clinically or by biopsy, angiography, and echocardiogram. We found a 
significant difference (pc.01) in BNP levels between patients with evidence of pathology 
and those without. Additionally, a BNP level of greater than 100 pS/mL had a 100% sen- 
sitivity (95% Confidence Interval: 68.100%) and a 100% negative predictive value (83. 
100%) for identifying any pathology in the transplanted heart Specificity was 78% (60. 
90%) and positive predictive value 61% (36.82%). 
Conclusions BNP appears to be a highly sensitive test to identify pediatric OHT 
patients at risk for rejection or transplant coronary artery disease. 
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410-4 Prognostic Importance of Presenting Symptoms in 
Patients Undergoing Exercise Testing for Evaluation of 
Known or Suspected Coronary Disease: A Propensity 
Analysis 
R. Christopher Jones, Claire E. Pothier, Eugene H. Blackstone, Michael S. Lauer. The 
Cleveland Clinic Foundation, Cleveland, OH 
Background: Chest symptoms, along with standard risk factors, are factored into pre- 
test risk stratification among patients who are candidates for stress testing. The indepen- 
dent pre- and post-test predictive values of symptoms are unclear. 
Methods: We studied the outcomes of 10,870 patients referred for symptom-limited 
exercise testing who had no history of myocardial revascularization, heart failure, atrial 
fibrillation, or pacemakers. Symptoms were classified according to pre-specified defini- 
tions. Propensity analysis was used to account for selection biases and baseline differ- 
ences. 
Results: Symptoms of typical angina were present in 635 patients (6%), of atypical 
angina in 3,408 (33%), of non-angina1 chest pain in 1,805 (17%). of dyspnea in 841 (a%), 
